156 related articles for article (PubMed ID: 33087128)
1. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
[TBL] [Abstract][Full Text] [Related]
2. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
[TBL] [Abstract][Full Text] [Related]
3. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
Sethi S; Oh S; Chen A; Bellinger C; Lofaro L; Johnson M; Huang J; Bhorade SM; Bulman W; Kennedy GC
BMC Pulm Med; 2022 Jan; 22(1):26. PubMed ID: 34991528
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
Mazzone P; Dotson T; Wahidi MM; Bernstein M; Lee HJ; Feller Kopman D; Yarmus L; Whitney D; Stevenson C; Qu J; Johnson M; Walsh PS; Huang J; Lofaro LR; Bhorade SM; Kennedy GC; Spira A; Rivera MP; ;
PLoS One; 2022; 17(7):e0268567. PubMed ID: 35830375
[TBL] [Abstract][Full Text] [Related]
5. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
[TBL] [Abstract][Full Text] [Related]
6. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
[TBL] [Abstract][Full Text] [Related]
7. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
[TBL] [Abstract][Full Text] [Related]
8. Analytical performance of Envisia: a genomic classifier for usual interstitial pneumonia.
Choi Y; Lu J; Hu Z; Pankratz DG; Jiang H; Cao M; Marchisano C; Huiras J; Fedorowicz G; Wong MG; Anderson JR; Tom EY; Babiarz J; Imtiaz U; Barth NM; Walsh PS; Kennedy GC; Huang J
BMC Pulm Med; 2017 Nov; 17(1):141. PubMed ID: 29149880
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
Pavel AB; Campbell JD; Liu G; Elashoff D; Dubinett S; Smith K; Whitney D; Lenburg ME; Spira A;
Cancer Prev Res (Phila); 2017 Nov; 10(11):651-659. PubMed ID: 28877936
[TBL] [Abstract][Full Text] [Related]
10. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
[TBL] [Abstract][Full Text] [Related]
12. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
Lee HJ; Mazzone P; Feller-Kopman D; Yarmus L; Hogarth K; Lofaro LR; Griscom B; Johnson M; Choi Y; Huang J; Bhorade S; Spira A; Kennedy GC; Wahidi MM;
Chest; 2021 Jan; 159(1):401-412. PubMed ID: 32758562
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms.
Hao Y; Duh QY; Kloos RT; Babiarz J; Harrell RM; Traweek ST; Kim SY; Fedorowicz G; Walsh PS; Sadow PM; Huang J; Kennedy GC
BMC Syst Biol; 2019 Apr; 13(Suppl 2):27. PubMed ID: 30952205
[TBL] [Abstract][Full Text] [Related]
14. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
[TBL] [Abstract][Full Text] [Related]
15. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
[TBL] [Abstract][Full Text] [Related]
18. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
[TBL] [Abstract][Full Text] [Related]
19. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
[TBL] [Abstract][Full Text] [Related]
20. Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience.
Zhang L; Smola B; Lew M; Pang J; Cantley R; Pantanowitz L; Heider A; Jing X
Diagn Cytopathol; 2021 Aug; 49(8):921-927. PubMed ID: 34021740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]